The dietary supplement industry is navigating a complex and rapidly evolving regulatory landscape, marked by uncertainty, shifting priorities, and a myriad of challenges. This article delves into the key takeaways from the 14th Annual ACI-CRN Legal, Regulatory and Compliance Forum, offering insights into how businesses are recalibrating their risk management strategies in the face of these changes. With a focus on regulatory risk, the industry is grappling with the need to balance innovation with compliance, as highlighted by the MAHA movement's push for ingredient transparency and the elimination of the GRAS loophole. The article explores the evolving relationship between scientific developments and legal definitions, particularly in the context of dietary ingredients and their market entry. It also examines the impact of new dietary ingredient (NDI) guidance on businesses, prompting them to reassess their regulatory strategies and consider the NDI pathway. The industry is witnessing a transformation driven by consumer demand for transparency, contaminant testing, and preventative health, alongside the growing trend of dietary supplements being delivered as food. As the industry adapts to these changes, it is crucial for companies to build regulatory, legal, quality, and commercial review into the earliest stages of innovation, strengthen supplier engagement, and maintain a written rationale for key decisions. Additionally, monitoring a broader range of entities, utilizing technology for risk monitoring, and carefully assessing functional food products are essential strategies for navigating the current regulatory environment. The article concludes by emphasizing the importance of maintaining consumer trust and safety as the foundation for long-term brand resilience in this dynamic industry.
